Search Result "Darapladib"

Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 3656-3661
Author(s): Alexandros D. Tselepis, Manfredi Rizzo, Ioannis A. Goudevenos

Research Article

Reduction in Vasa Vasorum Angiogenesis by Lp-PLA2 Selective Inhibitor Through The HIF-1α and VEGF Expression Under Dyslipidemic Conditions in Atherosclerosis Pathogenesis

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 16 Issue: 2 Year: 2018 Page: 114-119
Author(s): Teuku Heriansyah,Nafisa Nafisatuzzamrudah,Fitria Nugraha Aini,Muhammad Ridwan,Rozah F. Primardhika,Maya Wijayanti,Rachmad S. Bekti,Titin Andri Wihastuti

Review Article

Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease

Journal: Current Pharmaceutical Design
Volume: 24 Issue: 3 Year: 2018 Page: 291-296
Author(s): Areti Sofogianni,Stelina Alkagiet,Konstantinos Tziomalos

Review Article

Phospholipase A2 is an Inflammatory Predictor in Cardiovascular Diseases: Is there any Spacious Room to Prove the Causation?

Journal: Current Cardiology Reviews
Volume: 16 Issue: 1 Year: 2020 Page: 3-10
Author(s): Anwar Santoso,Teuku Heriansyah,Mohammad S. Rohman

Lipoprotein-Associated Phospholipase A2: How Effective as a Risk Marker of Cardiovascular Disease and as a Therapeutic Target?

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 10 Issue: 4 Year: 2011 Page: 236-246
Author(s): Mohamed S. Ahmed, Jing Zhan Ji, Qing H. Meng

Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6256-6269
Author(s): Constantinos C. Tellis, Alexandros D. Tselepis

Review Article

Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases

Journal: Current Drug Targets
Volume: 17 Issue: 1 Year: 2016 Page: 1940-1962
Author(s): Nagendra Sastry Yarla, Anupam Bishayee, Lakshmipathi Vadlakonda, Ramakrishna Chintala, Govinda Rao Duddukuri, Pallu Reddanna, Kaladhar S.V.G.K. Dowluru

Review Article

Targeting Inflammation in Primary Cardiovascular Prevention

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 3 Year: 2016 Page: 5662-5675
Author(s): Federico Carbone, Luca Liberale, Aldo Bonaventura, Michele Cea, Fabrizio Montecucco

Can Lipoprotein-associated Phospholipase A2 be Used as a Predictor of Long-term Outcome in Patients with Acute Coronary Syndrome?

Journal: Current Cardiology Reviews
Volume: 9 Issue: 4 Year: 2013 Page: 310-315
Author(s): Sine Holst-Albrechtsen, Maria Kjaergaard, Anh-Nhi Thi Huynh, Johanne Kragh Sorensen, Susanne Hosbond, Mads Nybo

Inflammatory Biomarkers and Cardiovascular Risk Assessment. Current Knowledge and Future Perspectives

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 3827-3840
Author(s): Elisavet Moutzouri, Vasilis Tsimihodimos, Alexandros D. Tselepis

Previous   Next

Go To   Results 1 - 1 of 42

Filter Result

Volume Year
© 2022 Bentham Science Publishers | Privacy Policy